Inflammatory bowel disease: clinical aspects and treatments.
about
Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature ReviewMedical Therapy of Perianal Crohn's DiseaseAn evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharidesInflammatory Potential of Diet and Risk of Ulcerative Colitis in a Case-Control Study from IranChronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis miceAssessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis.The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.Correlation between triggering receptor expressed on myeloid cells-1 and clinical disease activity in Chinese patients with ulcerative colitis.Myeloid-derived suppressor cells in inflammatory bowel disease.TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease.IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice.Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.Oral Manifestations of Inflammatory Bowel Diseases: Two Case Reports.Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function.Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study.Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease.Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases.Perioperative Parenteral Nutrition in Adults With Inflammatory Bowel Disease: A Review of the Literature.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Methionine restriction fundamentally supports health by tightening epithelial barriers.Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of β-cells.Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line.The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.Piperine Suppresses the Expression of CXCL8 in Lipopolysaccharide-Activated SW480 and HT-29 Cells via Downregulating the Mitogen-Activated Protein Kinase Pathways.Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease.Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model.Influence of Repeated Senna Laxative Use on Skin Barrier Function in Mice.Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study.Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberineHsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways.Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.Resveratrol Role in Autoimmune Disease-A Mini-Review.Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients.Wasabia japonica is a potential functional food to prevent colitis via inhibiting the NF-κB signaling pathway.Hypoxia-sensitive pathways in intestinal inflammation.Thyroid Dysfunction, Neurological Disorder and Immunosuppression as the Consequences of Long-term Combined Stress.
P2860
Q26752647-DF46B016-9B02-4D1F-B154-ECBF1EC3EEC1Q26777722-5E4DB819-2C6B-4DD6-A573-27FECDF64425Q28385065-3281542D-585B-4CDC-8350-CBE4E5A6C6EEQ28395360-C6B3D657-37C5-419F-99A1-DB8DE059F62CQ28608251-1915E2C8-BF8A-47C9-B508-61A5AF9E4945Q31146183-BCD2EBA6-1337-482B-9363-804949907148Q33577019-DD4C2150-FCE1-4E76-92E2-59CE0064DB55Q35480033-ECC02B5A-4BAA-4604-A68E-311E6CC22709Q35554166-4327FAF9-A02F-4104-9846-BD7271E1EE5FQ36085572-56D726D5-AB7A-4229-92F1-911C6381DD2DQ36207151-76BF4314-6DBF-48F5-ACA1-18FCA6903203Q36254533-1BE4DB65-4CF7-44A5-8217-D6B864F38DF1Q36357175-3E0F5487-3CA6-4453-9193-CBD9289C5326Q36793577-1EDEF59D-DC94-4353-8D74-B871FF94E90FQ36852795-375EA354-4005-48F3-861A-4D3844A30DE0Q37325113-0FCBAD24-C1D5-4A95-A6F5-4291CC04DD9EQ37369677-C2E03A78-051F-466D-98E7-8B124A45CF4EQ38413494-AC2965D8-FBA7-4E3A-847D-498F76324AC5Q38461139-920EFE3D-8296-429D-89E1-2258275325C1Q38489805-C4097693-600D-4928-9C16-DAA84D291C01Q38561334-A11CA407-979D-44BB-A464-320FC5C8656DQ38659150-8CCA834A-81D4-4DA5-B31B-E2DCBF57C240Q38662791-A46A9AA9-7754-4812-AD30-DCA5A2EB4D41Q38792786-9073F188-0C03-4115-99AA-06546DCB9CC3Q38834909-0849EFBC-1362-4221-9393-976FA69F78B6Q38846334-43E903C7-A8D5-463F-AC36-E5CD731DAE55Q38932478-9A8D2F57-B90D-4574-968C-1856F2F366B0Q39132618-5339C095-4256-4782-87DD-0C2598B7ECF6Q40898927-305850CB-046A-46F5-AAB4-65F60D248BF6Q40955416-4D8CA548-11F9-4D8A-9C81-C61F4040F3E2Q40987050-7EB50771-33C3-460F-B8AC-47C06F992951Q41548341-EB40A146-3A55-4612-802B-3B4EF3727DF1Q41588684-0582DA68-9030-4093-8DAC-C64209A03829Q41867495-9B5A1D4D-B734-41C3-97BD-99AD85AC6C46Q42030296-D48A37AA-FA1C-440D-AD62-409EC0EBE9CCQ47158536-C1ED3620-F067-4556-92CE-C165E72C0781Q48038691-86C70B0F-7449-47BE-85CB-5FD050D4A1A1Q48095567-C819B06F-E8C6-43FA-9853-480FC3C5ABF4Q48346681-704D1915-22A9-4CF5-AB2F-C99A28FEBB27Q53434112-6DEA35AE-2F9B-4F73-98C0-270C9045F457
P2860
Inflammatory bowel disease: clinical aspects and treatments.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inflammatory bowel disease: clinical aspects and treatments.
@ast
Inflammatory bowel disease: clinical aspects and treatments.
@en
Inflammatory bowel disease: clinical aspects and treatments.
@nl
type
label
Inflammatory bowel disease: clinical aspects and treatments.
@ast
Inflammatory bowel disease: clinical aspects and treatments.
@en
Inflammatory bowel disease: clinical aspects and treatments.
@nl
prefLabel
Inflammatory bowel disease: clinical aspects and treatments.
@ast
Inflammatory bowel disease: clinical aspects and treatments.
@en
Inflammatory bowel disease: clinical aspects and treatments.
@nl
P2860
P50
P356
P1476
Inflammatory bowel disease: clinical aspects and treatments.
@en
P2093
Rebecca Negrulj
P2860
P304
P356
10.2147/JIR.S65979
P407
P577
2014-06-23T00:00:00Z